Is the honeymoon over?, page-200

First 200 Last

Share
Profile

Follow
gsad1000

5,998 Posts.

525

29/10/17

17:13

Post #: 28291851
Share

Originally posted by Northen_munky ↑

Hi G

I personally think the coy was making comments without the bottom line signed as though it was a given and of course it wasn't.... Eventually this will come and bite you in the perverbial as it has with the military..they throw a spanner in the works and unfortunately it's not a Two week fix hence the extended lead time to completed product, evaluation and sales , is it coming? yep, when ? my gut tells me sooner rather than later..DVH seemed to be pretty confident when talking about the military..Once we have it will take a while to get some runs (revenue) on the board but the prestige alone will lift the SP..Nothing like a signed government contract to excite investors..

I was always concerned at the transition between NC and DVH and thought the Sp may take a dip ( thats an under statement) but we have been through the wringer particulary in the last couple of weeks and the negativity is being played with to conjure more cheap shares (imo).....

A little below my Average but i am starting to average down considerably ( selling other stocks )..too many irons in the fire for me to ignore this stock...for me it's worth the gamble ..Good luck to all who have stayed in and also good luck to those that have left for pastures new...where all here to make money..

As Pinto used to say...

Have a great Day all...

Laters...

Expand

I agree, although market continuous disclosure rules means they had to say something.

AJX Price at posting: 33.5¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

There are more pages in this discussion • 52 more messages in this thread...

First 200 Last

Add AJX (ASX) to my watchlist

(20min delay)
Last 1.3¢		Change 0.000(0.00%)		Mkt cap ! $20.46M

Open	High	Low	Value	Volume
1.4¢	1.4¢	1.3¢	$2.2K	157.6K

Buyers (Bids)

No.	Vol.	Price($)
1	42000	1.2¢

Sellers (Offers)

Price($)	Vol.	No.
1.5¢	906200	4

View Market Depth

No.	Vol.	Price($)
1	42000	0.012
3	4058332	0.010
5	2072715	0.009
3	1186222	0.008
2	240000	0.007

Price($)	Vol.	No.
0.015	906200	4
0.016	429958	1
0.017	321118	2
0.018	115942	2
0.019	12500	1

Last trade - 14.20pm 07/10/2024 (20 minute delay)

AJX (ASX) Chart

Is the honeymoon over?, page-200

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Is the honeymoon over?, page-200

Top Stories

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News